Company Overview and News

 
Long Island Iced Tea Corp. Announces Changes in Senior Executives as the Company Continues Strong Growth Momentum

2017-07-13 marketwired
HICKSVILLE, NY--(Marketwired - Jul 13, 2017) - Long Island Iced Tea Corp. (NASDAQ: LTEA) (the "Company"), a growth-oriented company focused on the non-alcohol ready-to-drink ("NARTD") tea segment in the beverage industry, today announced a number of changes to its senior executive line-up.

 
Merewether favourite Burwood Inn hits market as pub demand soars

2017-02-10 theage.com.au
High demand for pubs has prompted Newcastle's Ian Burford to offer the Burwood Inn for sale through Daniel Dragicevich and Ben McDonald from CBRE Hotels, in conjunction with Deane Moore from Moore and Moore Real Estate.

 
Merewether favourite Burwood Inn hits market as pub demand soars

2017-02-10 smh.com.au
High demand for pubs has prompted Newcastle's Ian Burford to offer the Burwood Inn for sale through Daniel Dragicevich and Ben McDonald from CBRE Hotels, in conjunction with Deane Moore from Moore and Moore Real Estate.

 
John Singleton and Geoff Dixon's pub fund sells three pubs for $47 million

2016-12-23 theage.com.au
In one of the last big deals for the year, good mates and businessmen Geoff Dixon and John Singleton have sold three iconic Sydney pubs as part of the divestment program by their $300 million Australian Pub Fund.

 
John Singleton and Geoff Dixon's pub fund sells three pubs for $47 million

2016-12-23 smh.com.au
In one of the last big deals for the year, good mates and businessmen Geoff Dixon and John Singleton have sold three iconic Sydney pubs as part of the divestment program by their $300 million Australian Pub Fund.

 
Lantern Hotel Group sells Five Dock pub for $28.75m

2016-11-21 theage.com.au
The Lantern Hotel Group has entered into a contract to sell its freehold Five Dock Hotel for $28.75 million, as it continues with its asset sale program.

 
Lantern Hotel Group sells Five Dock pub for $28.75m

2016-11-21 smh.com.au
Former Wallaby Bill Young has paid $28.75 million for the freehold Five Dock Hotel, which is being sold by the Lantern Hotel Group, as part of its asset restructure program.

 
Bega's Barry Irvin can't find the magic formula to crack Chinese market

2016-10-25 theage.com.au
It was meant to be the magic formula for Bega Cheese investors –- team up with China darling, Blackmores, in the infant formula market and watch the money roll in.

 
Bega's Barry Irvin can't find the magic formula to crack Chinese market

2016-10-25 smh.com.au
It was meant to be the magic formula for Bega Cheese investors –- team up with China darling, Blackmores, in the infant formula market and watch the money roll in.

 
Lantern Hotel group raises $14.5m from asset sale

2016-10-18 theage.com.au
The listed pub owner Lantern Group has raised $14.5 million from the sale of the Commodore Hotel in Sydney's north shore as part of its ongoing non-core asset divestment program.

 
Lantern Hotel group raises $14.5m from asset sale

2016-10-18 smh.com.au
The listed pub owner Lantern Group has raised $14.5 million from the sale of the Commodore Hotel in Sydney's north shore as part of its ongoing non-core asset divestment program.

 
Commodore Hotel hits the market

2016-09-16 theage.com.au
The 150-year-old Commodore Hotel, said to be Henry Lawson's preferred watering hole, is on the market at a time when A-grade freehold hotels are being actively sought by investors spreading their interest to the suburbs.

 
Commodore Hotel hits the market

2016-09-16 smh.com.au
The 150-year-old Commodore Hotel, said to be Henry Lawson's preferred watering hole, is on the market at a time when A-grade freehold hotels are being actively sought by investors spreading their interest to the suburbs.

 
Investor Update

2016-05-09 asx.com.au

 
Sale of GPO Hotel

2016-05-02 asx.com.au

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

20h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...